The European vascular access device market is well-established and will grow marginally over the forecast period. Unit sales will be supported by steady growth in the underlying patient population…
The European neurovascular device market will see strong growth through 2032 driven by the launch and increasing adoption of new devices backed by favorable clinical data as well as access to the…
The Asia Pacific spinal implant market will continue to experience strong growth throughout the forecast period. The uptake of premium innovations such as 3-D printed implants, nonfusion…
The European reconstructive small-joint market has largely recovered from the negative impacts of the COVID-19 pandemic and will resume prepandemic growth trends in the near term; going forward,…
The European interventional oncology device market will see moderate growth through 2032, driven by improved reimbursement, increasing popularity of minimally invasive surgeries, and growing…
Although the global COVID-19 pandemic negatively impacted the Asia Pacific structural heart closure device market in 2020, strong prepandemic growth trends in the PFO and LAA segments helped to…
The European CRM device market will continue to experience modest growth through 2032, primarily due to increasing adoption of premium-priced devices such as leadless pacemakers and S-ICDs. However…
Driven by product awareness, rising kidney stone prevalence, and an aging population, the Asia Pacific urological device market will grow at a modest rate through 2032, despite the short-term…
Although the global COVID-19 pandemic negatively impacted the Asia Pacific EP mapping and ablation device market in 2020, the market has shown strong recovery and will resume prepandemic growth…
Following recovery from the impact of the COVID-19 pandemic, the European neurostimulation device market will see modest growth through 2032, driven by ongoing product innovation and a focus on…
The US pain management device market is characterized by ongoing product innovation to improve treatment efficacy and to address new indications, with new clinical evidence and pain management…
The US reconstructive small-joint implant market has largely recovered from the negative impacts of the COVID-19 pandemic and will resume prepandemic growth trends in the near term; going forward,…
The US neurostimulation device market is characterized by ongoing product innovation; iterative device improvements are regularly launching in established segments—such as the SCS and DBS device…
Over the forecast period, Latin American spinal implant market expansion will be driven by procedure volume growth due to an aging population and uptake of premium innovations such as 3-D–…
The US vascular access device market will grow slowly over the forecast period. On one hand, unit sales will be supported by steady growth in the underlying patient population undergoing medical…